TPG-owned clinical trials player raises new equity, debt
Novotech, an Asia-based clinical trials specialist controlled by TPG Capital, has secured USD 760m in new equity and debt financing at a post-deal valuation of approximately USD 3bn.
The company, which was said to be targeting a Hong Kong IPO, completed a USD 255m private placement with participation from global institutional investors, sovereign wealth funds, and specialist healthcare...
More on Australasia
Latest News
Mitsui, Nomura acquire real assets manager New Forests
Japan’s Mitsui & Co. and Nomura Holdings have agreed to acquire 100% of New Forests, an Australia-headquartered sustainable real assets investment manager focused on forestry, land management, and conservation.
Thai food supply chain player secures $23.5m Series B
Openspace Ventures has participated in a USD 23.5m Series B funding round for Freshket, a Thailand-based farm-to-table agricultural supply chain start-up.
Philippines fintech player Coins raises $30m
Coins, a Philippines-based financial technology provider focused on blockchain-enabled payment services, has received a USD 30m investment led by Ribbit Captial.
Coatue, Insight lead Series D for Indonesia's Xendit
Coatue Management and Insight Partners have led a USD 300m Series D round for Indonesian payments infrastructure platform Xendit.